CLSA Premium Ltd. (HK:6877) has released an update.
CLSA Premium Limited recently reported unaudited interim financial results for the first half of 2024, revealing a modest drop in profit from continuing operations compared to the same period in 2023. The company’s total income decreased significantly, mainly due to a reduction in sales from its healthcare business, while total expenses saw a slight decrease. Despite challenges, the firm managed to stay profitable with a comprehensive income for the period reflecting a slight increase from the previous year.
For further insights into HK:6877 stock, check out TipRanks’ Stock Analysis page.
